@article{39952296042443fe9bc68f46f5d0da23,
title = "Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE)",
abstract = "We assessed trends in treatment of patients with CRE from 2012 through 2018. We detected decreased utilization of aminoglycosides and colistin and increased utilization in extended-spectrum cephalosporins and ceftazidime-Avibactam. We found significant uptake of ceftazidime-Avibactam, a newly approved antibiotic, to treat CRE infections. ",
author = "Suda, {Katie J.} and Alfredo Traversa and Ursula Patel and Linda Poggensee and Fitzpatrick, {Margaret A.} and Wilson, {Geneva M.} and Evans, {Charlesnika T.}",
note = "Funding Information: This work was supported by The Department of Veterans{\textquoteright} Affairs, Veterans{\textquoteright} Health Administration, Office of Research and Development, Health Services Research and Development (grant no. IIR 16-028); by the Rehabilitation Research and Development Career Development Award (grant no. B2826-W to M.A.F.); and by a Research Career Scientist Award (grant no. RCS 20-192 to C.T.E). Publisher Copyright: {\textcopyright} Department of Veterans Affairs, 2021.",
year = "2021",
doi = "10.1017/ice.2021.452",
language = "English (US)",
journal = "Infection Control and Hospital Epidemiology",
issn = "0899-823X",
publisher = "University of Chicago Press",
}
